|
bioMérieux, a world leader in in vitro diagnostics
- consolidated sales of €1.223 billion in 2009
- nearly 6.500 employees
bioMérieux, specialized in the in vitro diagnostics sector, designs, develops, produces and markets diagnosis systems (reagents, instruments and software) for medical or industrial applications.
In vitro diagnostics tests are used to measure, identify and quantify bacteria and viruses as well as substances generated by the human body in the presence, for instance, of an infectious disease, a cancer or a cardiac pathology.
A worldwide presence in more than 150 countries
- 85% of 2009 consolidated sales from export
- 39 subsidiaries
An ambitious and effective research policy
- about 12 % of sales invested in Research and Development
- about 900 employees dedicated to research
- 12 research centers around the world
Two business areas
- Clinical diagnostics (85% of 2009 sales)
From biological fluids (blood, saliva, urine, etc.), this line of business focuses on diagnosing infectious diseases, such as hepatitis B, HIV, tuberculosis, respiratory infections and increasingly pathologies, such as cardio-vascular diseases and cancers.
- Industrial diagnostics (15% of 2009 sales)
This business focuses on controlling the microbiological quality of an industrial or environmental sample.
Your bioMérieux press contact:
Koren Wolman-Tardy
Phone: +33.4.7887.2008
E-mail: media@eu.biomerieux.com
Are you looking for the bioMérieux Corporate website?
A priority: fighting infectious diseases
|